Taken together, these findings strongly demonstrate that Chfr and p53 are key negative regulators of Aurora-A kinase signaling, and their loss of function promotes a growth advantage for cancer cells through increased expression of Aurora-A. This evidence concerns the gene TP53 and cancer.